LexDanaLexDanabeta
Inventor

Denise M. Kenski

Inventor
San Francisco, CA, US

Overview

7→
Patents
2014–2020
Patent span
Chemistry
Primary field (CPC C)

Patents· 7 as inventor

Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.

C12Nprimary
C12NMicroorganisms or enzymes38%
A61KPreparations for medical, dental or toiletry purposes15%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations15%
C07HSugars15%
C12QMeasuring or testing processes involving enzymes, nucleic acids or microorganisms15%
PatentTitleYear
10,689,648Short interfering nucleic acid (siNA) compositions20209,970,005RNA interference mediated inhibition of gene expression using short interfering nucleic acids (siNA)20189,631,240'Genetic variations associated with tumors'20179,512,426'Method for rapidly evaluating performance of short interfering RNA with novel chemical modifications'20169,260,471'RNA interference mediated inhibition of gene expression using short interfering nucleic acids (siNA)'20168,877,439'Method for rapidly evaluating performance of short interfering RNA with novel chemical modifications'20148,680,041'Genetic variations associated with tumors'2014

Career & activity timeline

Assembled from patent assignee/location history and declaration credentials.

2014–2020Patents assigned to SIRNA THERAPEUTICS INC (5)· patent assignee history
2014–2017Patents assigned to GENENTECH INC (2)· patent assignee history
2014Patents assigned to KENSKI DENISE M (2)· patent assignee history
2014Patents assigned to BUTORA GABOR (1)· patent assignee history
2014–2020Based in San Francisco, CA, US· patent location history
2016Patents assigned to CANCILLA MARK (1)· patent assignee history

Inventor activity

Assignee and location history derived from the patent record.

Assignees
AssigneePatentsSpan
SIRNA THERAPEUTICS INC52014–2020
GENENTECH INC22014–2017
KENSKI DENISE Mself22014
BUTORA GABOR12014
CANCILLA MARK12016
Locations
LocationPatentsSpan
San Francisco, California, US72014–2020